Daunorubicin - HY-13062A
Nur noch %1 verfügbar
Catalog #
HY-13062A
Ab
42,00 €
Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor[1][2][4][5].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-13062A/Daunorubicin-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | Daunomycin; RP 13057; Rubidomycin |
| CAS | 20830-81-3 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 527.52 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | ADC Payload;Antibiotic;Apoptosis;Autophagy;Bacterial;DNA/RNA Synthesis;Topoisomerase |
| Application: | Cancer-programmed cell death |
|---|